Insider · CIK 0001314756

Geffken Daniel E.

Reports to the SEC for 7 companies · WARRINGTON, PA

sec.gov

Transactions

Companies

Filings

CIK

0001314756

Forms 4 and 5

Insider transactions

19 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2024-05-17	CALCCalciMedica, Inc. · WarrantA Award	Interim CFO	AAward	+10K sh	—	—	10,000
2024-02-14	CEROCERO THERAPEUTICS HOLDINGS, INC.J Other	Chief Financial Officer	JOther	+10K sh	—	—	10,002
2023-10-26	PMNProMIS Neurosciences Inc. · Option (right to buy)A Award	Chief Financial Officer	AAward	+2,500 sh	—	—	2,500
2023-08-23	WINTWINDTREE THERAPEUTICS INC /DE/A Award	Director	AAward	+2,033 sh	—	—	2,175
2023-08-23	WINTWINDTREE THERAPEUTICS INC /DE/ · Stock Option (Right to Buy)A Award	Director	AAward	+3,050 sh	—	—	3,050
2023-03-20	CALCCalciMedica, Inc. · WarrantA Award	Interim CFO	AAward	+5,760 sh	—	—	5,760
2023-03-20	CALCCalciMedica, Inc. · WarrantA Award	Interim CFO	AAward	+11.5K sh	—	—	11,520
2022-06-07	WINTWINDTREE THERAPEUTICS INC /DE/A Award	Director	AAward	+5,000 sh	—	—	7,069
2022-06-07	WINTWINDTREE THERAPEUTICS INC /DE/ · Stock Option (Right to Buy)A Award	Director	AAward	+7,500 sh	—	—	7,500
2021-11-29	ELOXEloxx Pharmaceuticals, Inc.P Purchase	INTERIM CFO	PPurchase	+50K sh	$0.72	+$36K	50,000
2021-10-08	CEROCERO THERAPEUTICS HOLDINGS, INC. · Class B Common StockJ Other	Chief Financial Officer	JOther	+30K sh	—	—	30,000
2021-06-15	WINTWINDTREE THERAPEUTICS INC /DE/ · Stock Option (Right to Buy)A Award	Director	AAward	+15K sh	—	—	15,000
2021-04-20	ELOXEloxx Pharmaceuticals, Inc. · Non-Qualified Stock Option (right to buy)A Award	INTERIM CFO	AAward	+100K sh	—	—	100,000
2021-02-03	WINTWINDTREE THERAPEUTICS INC /DE/ · Stock Option (Right to Buy)A Award	Director	AAward	+15K sh	—	—	15,000
2021-01-12	eFFECTOR Therapeutics, Inc.Class B Common StockJ Other	Chief Financial Officer	JOther	−20K sh	—	—	20,000
2020-05-22	WINTWINDTREE THERAPEUTICS INC /DE/ · Common Stock WarrantsP Purchase	Director	PPurchase	+2,069 sh	—	—	2,069
2020-05-22	WINTWINDTREE THERAPEUTICS INC /DE/P Purchase	Director	PPurchase	+2,069 sh	$7.25	+$15K	2,069
2019-04-24	WINTWINDTREE THERAPEUTICS INC /DE/ · Non-Qualified Stock Option (Right to Buy)A Award	Director	AAward	+60K sh	—	—	60,000
2005-03-30	Cyberkinetics Neurotechnology Systems, Inc.Stock OptionA Award	Director	AAward	+5,000 sh	—	—	5,000

Recent filings

Accepted (ET)
May 204
Geffken Daniel E.0001415889-24-013834
SEC(opens sec.gov)
Feb 164
Geffken Daniel E.0001213900-24-015030
SEC(opens sec.gov)
Oct 304
Geffken Daniel E.0000950170-23-056495
SEC(opens sec.gov)
Aug 294
Geffken Daniel E.0001437749-23-024844
SEC(opens sec.gov)
May 34
Geffken Daniel E.0001209191-23-027199
SEC(opens sec.gov)
Jun 94
Geffken Daniel E.0001437749-22-014714
SEC(opens sec.gov)
Dec 14
Geffken Daniel E.0001415889-21-005600
SEC(opens sec.gov)
Oct 124
Geffken Daniel E.0000899243-21-039940
SEC(opens sec.gov)
Jun 174
Geffken Daniel E.0001437749-21-015118
SEC(opens sec.gov)
Apr 224
Geffken Daniel E.0001415889-21-002054
SEC(opens sec.gov)
Feb 54
Geffken Daniel E.0001437749-21-002147
SEC(opens sec.gov)
Jan 144
Geffken Daniel E.0000899243-21-002109
SEC(opens sec.gov)
May 274
Geffken Daniel E.0001437749-20-011866
SEC(opens sec.gov)
Apr 264
Geffken Daniel E.0001437749-19-008083
SEC(opens sec.gov)
Apr 114
GEFFKEN DANIEL E0000898432-05-000318
SEC(opens sec.gov)

Companies

Address

C/O WINDTREE THERAPEUTICS, INC. 2600 KELLY ROAD, SUITE 100

WARRINGTON, PA, 18976